The bill introduced by Senator Craig, along with several cosponsors, aims to enact a new section, 3902.65, in the Revised Code of Ohio, which specifically addresses the cost-sharing requirements for prescription insulin drugs. The bill defines "prescription insulin drug" as any prescription medication containing insulin used for diabetes treatment. It establishes a cap on the cost-sharing amount that health plan issuers can require for these drugs, limiting it to a maximum of thirty-five dollars for a thirty-day supply, regardless of the type or amount of insulin prescribed.

This legislation overrides existing provisions in section 3901.71 of the Revised Code, ensuring that any health benefit plans amended, issued, or renewed after the bill's effective date adhere to this new cost-sharing limit. The intent of the bill is to alleviate the financial burden on individuals requiring insulin, making it more accessible for those managing diabetes.